{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:49:45Z","timestamp":1768528185325,"version":"3.49.0"},"reference-count":12,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Systemic inflammation plays a central role in the pathogenesis and progression of type 2 diabetes mellitus (T2DM). Hematologic inflammatory indices-such as the Systemic Immune-Inflammation Index (SII), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Monocyte-to-Lymphocyte Ratio (MLR)-have emerged as accessible markers of chronic inflammation, yet longitudinal comparisons across oral antidiabetic therapies remain limited. This study uniquely integrates longitudinal correlation and network analyses in a large real-world T2DM cohort, allowing assessment of the temporal stability and class-specific inflammatory patterns across four oral antidiabetic therapies. Methods: This retrospective, longitudinal study analyzed 13,425 patients with T2DM treated with Biguanidines, Dipeptidyl Peptidase-4 (DPP-4) inhibitors, Sodium\u2013Glucose Cotransporter-2 (SGLT-2) inhibitors or Thiazolidinediones (TZDs) between 2020 and 2024. Data were retrieved from the Probel\u00ae Hospital Information System and included baseline, early (30\u2013180 days), and late (180\u2013360 days) follow-up laboratory results. Systemic inflammatory indices were computed from hematologic parameters, and correlations among inflammatory and biochemical markers were assessed using Spearman\u2019s coefficients. Results: At baseline, all hematologic indices were strongly intercorrelated (SII\u2013NLR r = 0.83, p &lt; 0.001; SII\u2013PLR r = 0.73, p &lt; 0.001), with moderate associations to C-reactive protein (CRP; r \u2248 0.3\u20130.4) and weak or no correlations with Ferritin (r \u2248 \u22120.1). These relationships remained stable throughout follow-up, confirming reproducibility of systemic inflammatory coupling. Longitudinally, SII and NLR showed modest early increases followed by significant declines at one year (p &lt; 0.05), while PLR and MLR remained stable. Class-specific differences were observed: SGLT-2 inhibitors and TZDs demonstrated stronger and more integrated anti-inflammatory networks, whereas Biguanidines and DPP-4 inhibitors exhibited moderate coherence. Principal Component Analysis (PCA) explained 62.4% of total variance and revealed distinct clustering for TZD and SGLT-2 groups, reflecting class-specific inflammatory modulation. Conclusions: Systemic inflammatory indices (SII, NLR, PLR) provide reproducible and accessible measures of low-grade inflammation in T2DM. Despite overall inflammation reduction with treatment, drug-specific patterns emerged-SGLT-2 inhibitors and TZDs showed greater anti-inflammatory coherence, while Biguanidines and DPP-4 inhibitors maintained moderate effects.<\/jats:p>","DOI":"10.3390\/jcm15020688","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:26:36Z","timestamp":1768465596000},"page":"688","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0486-4522","authenticated-orcid":false,"given":"Mehmet","family":"Yamak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Health Sciences Haseki Training and Research Hospital, 34096 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4393-9757","authenticated-orcid":false,"given":"Serkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Bayburt State Hospital, 69000 Bayburt, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-164X","authenticated-orcid":false,"given":"Sami","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Nephrology Medicine, University of Health Sciences Haseki Training and Research Hospital, 34096 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egemen","family":"Cebeci","sequence":"additional","affiliation":[{"name":"Department of Nephrology Medicine, University of Health Sciences Haseki Training and Research Hospital, 34096 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9938-1144","authenticated-orcid":false,"given":"\u00d6zlem","family":"Menken","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Defne State Hospital, 31160 Hatay, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-3810","authenticated-orcid":false,"given":"Savas","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Istanbul Faculty of Medicine, Istanbul University, 34104 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Leucu\u021ba, D.-C., Fumeaux, P.A., Alm\u0103\u0219an, O., Popa, \u0218.L., and Ismaiel, A. (2025). Inflammatory Markers as Predictors of Diabetic Nephropathy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Medicina, 61.","DOI":"10.3390\/medicina61020216"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.12669\/pjms.336.12900","article-title":"Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients","volume":"33","author":"Hussain","year":"2017","journal-title":"Pak. J. Med. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, J., Wang, X., Jia, W., Wang, K., Wang, W., Diao, W., Ou, F., Ma, J., and Yang, Y. (2024). Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1367376"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Xu, R., and Jiang, L. (2025). Association of systemic immune-inflammation index with type 2 diabetes mellitus and its prognostic significance: A systematic review and meta-analysis. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1572089"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pasqualetti, F., Giampietro, C., Montemurro, N., Giannini, N., Gadducci, G., Orlandi, P., Natali, E., Chiarugi, P., Gonnelli, A., and Cantarella, M. (2022). Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy. Genes, 13.","DOI":"10.3390\/genes13061054"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41435-018-0050-z","article-title":"Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations","volume":"20","author":"Li","year":"2019","journal-title":"Genes Immun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s41030-022-00211-x","article-title":"Utility of hypoglycemic agents to treat asthma with comorbid obesity","volume":"9","author":"Ge","year":"2023","journal-title":"Pulm. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Farrag, K., Aksan, A., Ademaj-Kospiri, V., Leventi, E., and Stein, J. (2024). Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia\u2014Lessons from Inflammatory Bowel Disease. Diagnostics, 14.","DOI":"10.3390\/diagnostics14141515"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e70000","DOI":"10.1002\/pmic.70000","article-title":"Serum Proteome Profiling of Diabetic Patients Treated With DPP4 and SGLT2 Inhibitors Shows Improved Cognitive and Cardiovascular Functions","volume":"25","author":"Hakim","year":"2025","journal-title":"Proteomics"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dong, Y., Tang, M., Xu, Y., and Peng, Q. (2025). Predictive value of systemic immune-inflammation index in patients with diabetes mellitus: A systematic review and meta-analysis. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1617814"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Craciun, L., Ignuta, F., Rayudu, U.S., Afra, M., Rosca, O., Vlad, A., Aburel, O., and Velimirovici, D.E. (2025). The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19. Biomedicines, 13.","DOI":"10.3390\/biomedicines13040886"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1111\/dom.15586","article-title":"The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials","volume":"26","author":"Buttice","year":"2024","journal-title":"Diabetes Obes. Metab."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/688\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:47:03Z","timestamp":1768470423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15020688"],"URL":"https:\/\/doi.org\/10.3390\/jcm15020688","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}